NCLAT: Can File App. u/s 7 of IBC when Entire Liability Not Discharged after Selling Pledged Shares  ||  NCLAT: Recovery Proceedings before DRT doesn’t Prohibit Financial Creditors from Filing App. u/s 7  ||  Ker. HC: Women Face Discrimination at Multiple Level Due to their Inter- Sectionality  ||  Del. HC: Amounts Received by ERC under Filing Fee, Tariff Fee Not Exigible to Tax  ||  Ker. HC: Equity, Justice, Convenience Govern the Question Whether Joint Trial is Required or Not  ||  Ker. HC: Equity, Justice, Convenience Govern the Question Whether Joint Trial is Required or Not  ||  Delhi HC: Benchmark of Rs. 50 Lakh Income to be Met at Initiation of Reassessment Proceedings  ||  MP HC: No Prohibition on Issuance of Passport without Father’s Consent  ||  Del. HC: Samsung India Electronics is Not Samsung Korea’s Permanent Establishment in India  ||  Guj. HC: Machines Used for Welding in Residential Society is Nuisance    

Finalization of Draft Rules on Sale of Drugs by E-Pharmacies- (Press Information Bureau) (25 Jun 2019)

MANU/PIBU/0667/2019

Law of Medicine

The Government has published draft rules vide G.S.R. 817 (E) dated 28th August 2018 for inviting public/stakeholder comments for amendment to the Drugs and Cosmetics Rules, 1945 for incorporating provisions relating to regulation of sale and distribution of drugs through e-pharmacy. A large number of suggestions/comments have been received from the stakeholders, which are being examined. At the same time, the matter is sub-judice before various Hon'ble High Courts in the country. Therefore, no timeline for finalization of the rules can be provided.

Under the Drugs & Cosmetics Act and Rules, sale of spurious drugs is a punishable offence and State Licensing Authorities are empowered to take action in this regard. Accordingly, the complaints as received, are referred to State Licensing Authorities for taking action as per the provisions of the Act and Rules.

Tags : DRAFT RULES   FINALIZATION   SALE OF DRUGS   E-PHARMACIES  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved